Cargando…
The development and validation of a circulating tumor cells-based integrated model for improving the indeterminate lung solid nodules diagnosis
BACKGROUND: There is a risk of over investigation and delayed treatment in the work up of solid nodules. Thus, the aim of our study was to develop and validate an integrated model that estimates the malignant risk for indeterminate pulmonary solid nodules (IPSNs). METHODS: Patients included in this...
Autores principales: | Wan, Ziwei, He, Hua, Zhao, Mengmeng, Ma, Xiang, Sun, Shuo, Wang, Tingting, Deng, Jiajun, Zhong, Yifan, She, Yunlang, Ma, Minjie, Wang, Haifeng, Chen, Qiankun, Chen, Chang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087991/ https://www.ncbi.nlm.nih.gov/pubmed/37057115 http://dx.doi.org/10.21037/tlcr-23-145 |
Ejemplares similares
-
Integrated Biomarkers for Indeterminate Pulmonary Nodules: Is 2-Year Imaging Follow-Up Enough for Suspected Benign Lesions?
por: Zhao, Mengmeng, et al.
Publicado: (2022) -
Implementation of artificial intelligence in the histological assessment of pulmonary subsolid nodules
por: Deng, Jiajun, et al.
Publicado: (2021) -
Prognostic Significance of the Proposed Residual Tumor Classification in Patients With NSCLC After Sleeve Lobectomy
por: Chen, Tao, et al.
Publicado: (2023) -
Feasibility of double sleeve lobectomy after neoadjuvant chemotherapy in patients with non-small-cell lung cancer
por: Bao, Yi, et al.
Publicado: (2022) -
Identification and evaluation of circulating small extracellular vesicle microRNAs as diagnostic biomarkers for patients with indeterminate pulmonary nodules
por: Zheng, Di, et al.
Publicado: (2022)